JP2010524894A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010524894A5 JP2010524894A5 JP2010503511A JP2010503511A JP2010524894A5 JP 2010524894 A5 JP2010524894 A5 JP 2010524894A5 JP 2010503511 A JP2010503511 A JP 2010503511A JP 2010503511 A JP2010503511 A JP 2010503511A JP 2010524894 A5 JP2010524894 A5 JP 2010524894A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phenyl
- optionally substituted
- carbocyclyl
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000002947 alkylene group Chemical group 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 2
- 125000004452 carbocyclyl group Chemical group 0.000 claims 2
- 229910052736 halogen Inorganic materials 0.000 claims 2
- 150000002367 halogens Chemical class 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims 1
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000005037 alkyl phenyl group Chemical group 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 0 C*(C)*c(cc1)cc2c1[n]c(*)n2 Chemical compound C*(C)*c(cc1)cc2c1[n]c(*)n2 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91254007P | 2007-04-18 | 2007-04-18 | |
| US60/912,540 | 2007-04-18 | ||
| PCT/EP2008/054711 WO2008128982A1 (en) | 2007-04-18 | 2008-04-18 | Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010524894A JP2010524894A (ja) | 2010-07-22 |
| JP2010524894A5 true JP2010524894A5 (OSRAM) | 2011-09-08 |
| JP5675341B2 JP5675341B2 (ja) | 2015-02-25 |
Family
ID=39684456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010503511A Expired - Fee Related JP5675341B2 (ja) | 2007-04-18 | 2008-04-18 | グルタミニルシクラーゼ阻害剤としてのチオキソキナゾリノン誘導体 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9034907B2 (OSRAM) |
| EP (1) | EP2160389B1 (OSRAM) |
| JP (1) | JP5675341B2 (OSRAM) |
| DK (1) | DK2160389T3 (OSRAM) |
| ES (1) | ES2478673T3 (OSRAM) |
| WO (1) | WO2008128982A1 (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7732162B2 (en) * | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| JP5676249B2 (ja) * | 2007-04-20 | 2015-02-25 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのアミノピリジン誘導体 |
| WO2009034158A2 (en) * | 2007-09-12 | 2009-03-19 | Probiodrug Ag | Transgenic mice |
| JP2011511622A (ja) * | 2008-01-14 | 2011-04-14 | プロビオドルグ エージー | グルタミニルシクラーゼ遺伝子のノックアウト変異を有するマウスモデル |
| BRPI0916366B1 (pt) | 2008-07-21 | 2021-08-10 | Probiodrug Ag | Anticorpo que se liga às variantes de peptídeos abeta, sua composição, seu uso, seu kit de diagnóstico, e linhagem celular de hibridoma |
| CA2759187A1 (en) * | 2009-04-03 | 2010-10-07 | Medisyn Technologies, Inc. | Compositions for treatment of alzheimer's disease |
| KR101755737B1 (ko) | 2009-09-11 | 2017-07-07 | 프로비오드룩 아게 | 글루타미닐 사이클라제의 억제제로서 헤테로사이클릭 유도체 |
| WO2011076854A1 (en) | 2009-12-22 | 2011-06-30 | Probiodrug Ag | CLEAVAGE OF β-AMYLOID PRECURSOR PROTEIN |
| EP2537029A1 (en) | 2010-02-18 | 2012-12-26 | Probiodrug AG | Methods of diagnosing inflammatory diseases by determining pyroglutamate-modified mcp-1 and screening methods for inhibitors of glutaminyl cyclase |
| WO2012058211A2 (en) * | 2010-10-29 | 2012-05-03 | Emory University | Quinazoline derivatives, compositions, and uses related thereto |
| MX343873B (es) | 2011-03-16 | 2016-11-25 | Probiodrug Ag | Ensayo de diagnostico de anticuerpo. |
| US20150110723A1 (en) * | 2012-05-31 | 2015-04-23 | Emory University | Quinazoline derivatives, compositions, and uses related thereto |
| EP3234611A1 (en) | 2014-12-19 | 2017-10-25 | Probiodrug AG | Novel method for the detection of pglu-abeta peptides |
| EP3386591B1 (en) | 2015-12-09 | 2020-06-24 | Cadent Therapeutics, Inc. | Heteroaromatic nmda receptor modulators and uses thereof |
| US10500205B2 (en) | 2015-12-09 | 2019-12-10 | Cadent Therapeutics, Inc. | Thienopyrimidinone NMDA receptor modulators and uses thereof |
| CA3047403A1 (en) | 2016-12-22 | 2018-06-28 | Cadent Therapeutics, Inc. | Nmda receptor modulators and uses thereof |
| PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
| EP3521308B1 (en) | 2018-01-31 | 2024-03-13 | Vivoryon Therapeutics N.V. | Humanized and de-immunized antibodies |
| US10584131B2 (en) | 2018-08-03 | 2020-03-10 | Cadent Therapeutics, Inc. | Heteroaromatic NMDA receptor modulators and uses thereof |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0293500A1 (en) | 1987-06-01 | 1988-12-07 | American Cyanamid Company | 3-heteroalkyl-2,4.quinzaoline-diones |
| US4684654A (en) | 1985-08-14 | 1987-08-04 | American Cyanamid Company | 3-heteroalkyl-2,4-quinzaolinediones |
| US6948038B2 (en) * | 2001-07-24 | 2005-09-20 | Microsoft Corporation | System and method for backing up and restoring data |
| WO2003053958A1 (en) | 2001-12-20 | 2003-07-03 | Celltech R & D Limited | Quinazolinedione derivatives |
| US7732162B2 (en) | 2003-05-05 | 2010-06-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases |
| DE602004026712D1 (de) | 2003-05-05 | 2010-06-02 | Probiodrug Ag | Medizinische verwendung von hemmern von glutaminyl und glutamatcyclasen |
| WO2004098591A2 (en) * | 2003-05-05 | 2004-11-18 | Probiodrug Ag | Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases |
| US8338120B2 (en) | 2003-05-05 | 2012-12-25 | Probiodrug Ag | Method of treating inflammation with glutaminyl cyclase inhibitors |
| WO2005039548A2 (en) | 2003-10-15 | 2005-05-06 | Probiodrug Ag | Use of effectors of glutaminyl and glutamate cyclases |
| US20050171112A1 (en) | 2003-11-03 | 2005-08-04 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
| US7667044B2 (en) | 2003-11-03 | 2010-02-23 | Probiodrug Ag | Compounds for the treatment of neurological disorders |
| CA2544573A1 (en) | 2003-11-03 | 2005-06-02 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
| KR101099206B1 (ko) * | 2004-02-05 | 2011-12-27 | 프로비오드룩 아게 | 신규한 글루타미닐 시클라제 저해제 |
| WO2008034891A2 (en) | 2006-09-21 | 2008-03-27 | Probiodrug Ag | Novel genes related to glutaminyl cyclase |
| US7741354B2 (en) | 2006-11-09 | 2010-06-22 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| US8420684B2 (en) | 2006-11-09 | 2013-04-16 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
| DK2091948T3 (da) | 2006-11-30 | 2012-07-23 | Probiodrug Ag | Nye inhibitorer af glutaminylcyclase |
| DK2121944T3 (da) | 2007-01-19 | 2011-10-31 | Probiodrug Ag | In vivo screeningsmodeller til behandling af Alzheimers sygdom og andre QPCT-relaterede lidelser |
| JP5612860B2 (ja) | 2007-03-09 | 2014-10-22 | プロビオドルグ エージー | グルタミニルシクラーゼ阻害剤としてのイミダゾ［１，５−ａ］ピリジン誘導体 |
-
2008
- 2008-04-18 JP JP2010503511A patent/JP5675341B2/ja not_active Expired - Fee Related
- 2008-04-18 US US12/105,849 patent/US9034907B2/en active Active
- 2008-04-18 WO PCT/EP2008/054711 patent/WO2008128982A1/en not_active Ceased
- 2008-04-18 ES ES08749601.4T patent/ES2478673T3/es active Active
- 2008-04-18 DK DK08749601.4T patent/DK2160389T3/da active
- 2008-04-18 EP EP08749601.4A patent/EP2160389B1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010524894A5 (OSRAM) | ||
| HRP20191102T1 (hr) | Sintetski međuprodukti za pripravu konjugata oligosaharid-protein | |
| JP2013508347A5 (OSRAM) | ||
| HUE042847T2 (hu) | A 44 xiloglukanáz család egyik variánsát tartalmazó felületaktív készítmény | |
| EP2213856A4 (en) | AUSPUFFROHR | |
| JP2010512298A5 (OSRAM) | ||
| EP2215068A4 (en) | ANTIDIABETIC TRICYCLIC COMPOUNDS | |
| DK3061467T3 (da) | Sårforbinding med en bakterieadsorberende sammensætning | |
| BRPI0922904A2 (pt) | "compostos" | |
| SE0601145L (sv) | Vakuumöppningar av höghastighetstyp | |
| BRPI0923786A2 (pt) | compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos | |
| EP2003132A4 (en) | HETERO COMPOUND | |
| JP2010504301A5 (OSRAM) | ||
| JP2015537008A5 (OSRAM) | ||
| ATE505186T1 (de) | Neue zusammensetzungen mit chinolin-verbindungen | |
| JP2011510079A5 (OSRAM) | ||
| EP2117306A4 (en) | NEUROGENIC COMPOUNDS | |
| JP2011037885A5 (OSRAM) | ||
| DE502005005800D1 (de) | Selbsteinstellendes Gleitstück für Teleskopkranausleger | |
| DOP2011000154A (es) | 3-aminociclopentancarboxamidas | |
| EP1759410A4 (en) | Organotinic precursor compositions | |
| ITTO20080025A1 (it) | Attrezzatura per l'esecuzione di fori secanti. | |
| DE602008005654D1 (de) | Farbstoffverbindungen | |
| SE0402103D0 (sv) | Novel compounds | |
| JP2009530486A5 (OSRAM) |